Kimball Electronics Announces Internal Promotions, Executive Retirements
JASPER, Ind., June 30, 2020 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (NASDAQ: KE), (the “Company”), today announced two new internal […]
Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
REDWOOD CITY, Calif. and BOSTON, June 30, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company […]
Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a […]
Delisting of Securities of Tuesday Morning Corp.; Reebonz Holding Limited; Taronis Technologies, Inc.; Extraction Oil & Gas, Inc.; Synthesis Energy Systems, Inc.; and Luckin Coffee Inc. from The Nasdaq Stock Market
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of […]
Amdocs Chosen by Three to Support its Enterprise Business in the UK in Multi-Year Deal
ST. LOUIS, June 30, 2020 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications […]
Akouos Announces Closing of Initial Public Offering
BOSTON, June 30, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing […]
Aravive Added to the Russell 2000® and Russell 3000® Indexes
HOUSTON, June 30, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the […]
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the […]
TELA Bio Announces Closing of Public Offering of Common Stock
MALVERN, Pa., June 30, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, […]
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments
— Appointed Nicholas Green as President and Chief Executive Officer —— Recorded Fourth Quarter Revenue of $12.6 Million and Annual […]
